Latest Industry Insights

As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.

Discover how induced pluripotent stem cell technology is solving scale and consistency issues in mesenchymal stem/stromal cell therapy manufacturing and learn about Cynata’s ongoing clinical trials.

James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, Ferrocalm^TM, and how its innovative strategy could reshape the future of gut health.

Portal Bio’s microfluidic technology enhances drug discovery and cell engineering by enabling efficient, scalable molecular delivery for sensitive cell types.

At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.

In this article, Technology Networks spoke with Dr. Jack Hoppin and Dr. John Babich from Ratio Therapeutics to learn more about the recent radiopharmaceutical revolution.

To explore how PROTACs are transforming drug discovery, we spoke with Robyn Stoller, business development manager at Cytiva.

In this interview, Technology Networks spoke with Dr. Lena Jonsson, product strategy manager at Cytiva, to explore the biological, clinical and technological frontiers shaping the next generation of ADCs.

In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.